⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AARD News
Aardvark Therapeutics, Inc. Common Stock
AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
globenewswire.com
AARD
AARD UPCOMING DEADLINE: SueWallSt Alerts Aardvark Therapeutics, Inc. Stockholders of Securities Class Action - Contact the Firm
prnewswire.com
AARD
Pomerantz Law Firm Announces the Filing of a Class Action Against Aardvark Therapeutics, Inc. and Certain Officers and Directors - AARD
prnewswire.com
AARD
Levi & Korsinsky Urges Aardvark Therapeutics, Inc. (AARD) Shareholders to Act Before Lead Plaintiff Deadline October 13, 2026
accessnewswire.com
AARD
AARD LAWSUIT ALERT: Levi & Korsinsky Notifies Aardvark Therapeutics, Inc. Investors - Lead Plaintiff Deadline October 13, 2026
accessnewswire.com
AARD
Join Class Action to Recover Losses from Aardvark Therapeutics, Inc. (AARD) - Contact Levi & Korsinsky Before October 13, 2026
accessnewswire.com
AARD
AARDVARK THERAPEUTICS (NASDAQ: AARD) SECURITIES CLASS ACTION: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Investors With Losses in Excess of $100K to Secure Counsel Before Important October 13 Deadline
accessnewswire.com
AARD
Class Action Initiated by Pomerantz LLP Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
Bragar Eagel & Squire, P.C. Urges Aardvark Therapeutics, Inc. Investors to Contact the Firm Seeking Lead Plaintiff Role Before October 13th
globenewswire.com
AARD
AARD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
AARD